ALDAGEN
ALDAGEN is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. We have four product candidates in clinical trials. Our most advanced product candidate is ALD-101. We are currently conducting a pivotal Phase 3 clinical trial of ALD-101 to evaluate its efficacy in improving umbilical cord blood, or cord blood, transplants used to treat inherited metabolic diseases in pediatric patients. We are also conducting or supporting Phase 1 or Phase 1/2 clinical trials of three other product candidates ALD--151 to improve cord blood transplants used for the treatment of leukemia; ALD-301 to treat critical limb ischemia; and ALD-201 to treat ischemic heart failure.
ALDAGEN
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.aldagen.com
Total Employee:
11+
Status:
Active
Contact:
919-484-2571
Email Addresses:
[email protected]
Total Funding:
64.53 M USD
Technology used in webpage:
CloudFront U.S. Server Location New Relic Citrix NetScaler
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Aurora Funds
The Aurora Funds investment in Series D - Aldagen
Intersouth Partners
Intersouth Partners investment in Series D - Aldagen
Harbert Growth Partners
Harbert Growth Partners investment in Series D - Aldagen
Tullis Health Investors
Tullis Health Investors investment in Series D - Aldagen
Tullis Health Investors
Tullis Health Investors investment in Series C - Aldagen
Intersouth Partners
Intersouth Partners investment in Series C - Aldagen
Harbert Growth Partners
Harbert Growth Partners investment in Series C - Aldagen
CNF Investments, LLC
CNF Investments, LLC investment in Series C - Aldagen
Piedmont Angel Network
Piedmont Angel Network investment in Series C - Aldagen
The Trelys Funds
The Trelys Funds investment in Series C - Aldagen
Official Site Inspections
http://www.aldagen.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Aldagen"
Aldagen Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Aldagen. Use the PitchBook Platform to explore the full profile.See details»
Aldagen - Crunchbase Company Profile & Funding
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.See details»
Aldagen, Inc - LinkedIn
Aldagen is a wholly-owned subsidiary of Cytomedix, Inc (BB:CMXI). The Aldagen subsidiary develops proprietary regenerative cell therapies in the vascular area. These cell therapeutics …See details»
Aldagen Inc - Company Profile and News - Bloomberg Markets
Company profile page for Aldagen Inc including stock price, company news, executives, board members, and contact informationSee details»
Aldagen - Products, Competitors, Financials, Employees, …
Aldagen is a non-operational, wholly owned subsidiary of Nuo. Impact of COVID-19 Pandemic on Financial Statements On March 11, 2020, the World Health Organization declared the …See details»
Aldagen - Funding, Financials, Valuation & Investors
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.See details»
Aldagen - Contacts, Employees, Board Members, Advisors & Alumni
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.See details»
Working at Aldagen: Employee Reviews | Indeed.com
Reviews from Aldagen employees about Aldagen culture, salaries, benefits, work-life balance, management, job security, and more.See details»
Aldagen, Inc - VentureRadar
Aldagen, Inc VentureRadar profile. Find out more about Aldagen, Inc including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Alagen Company Profile | Management and Employees List
Alagen Profile and History Alagen is a professional services organization that advises on the rapid evolution of cyber threats and recognizes the shortage of experienced and qualified resources …See details»
Alagen - Overview, News & Similar companies | ZoomInfo.com
Alagen is a professional services organization that advises on the rapid evolution of cyber threats and recognizes the shortage of experienced and qualified resources required to secure the …See details»
HIPAA Risk Assessment - Alagen
Alagen's HIPAA Risk Assessment Any organization who takes HIPAA seriously would benefit from our approach. Not only will our solution satisfy the HIPAA requirement, but it will deliver a …See details»
Aldagen - Crunchbase
Aldagen develops regenerative cell therapies for inherited metabolic diseases, leukemia, critical limb ischemia and ischemic heart failure.See details»
Alagen | KLAS Report - KLAS Research
Aug 28, 2020 Alagen provides cybersecurity services for companies in healthcare, finance, education, and more. This report is KLAS’ first look at the experience of Alagen healthcare …See details»
Healthcare Cybersecurity | Alagen
Alagen is deeply experienced with the nuances related to cybersecurity within healthcare and helps you to meet the unique security needs for your organization.See details»
Cyber Security Advisory services & Program | Alagen
Our CISO advisory services will build and manage your program, creating effective coalitions at the board-level so that your organization’s security program is fully aligned around the right …See details»
Alagen - Crunchbase Company Profile & Funding
Alagen is in response to the rapid evolution of cyber threats and the shortage of experienced resources qualified to keep businesses secure.See details»
Healthcare Tabletop Exercises - Alagen
Tabletop Exercise Results Alagen’s tabletop exercises are aimed at revealing an organization’s IR capability completeness and staff familiarity with associated technologies and processes. The …See details»
Alagen | Cloud Adoption and Enablement Solutions
A services-only cybersecurity provider, Alagen contributes deep experience and insight to help organizations align security investments to business needs and maximize the value realized …See details»
Ransomware Protection - Alagen
A partnership with Alagen brings highly-sought technical expertise, industry experience, and a myriad of tools to the forefront of your organization’s defenses.See details»